Effect of Mepolizumab on Decrease of Systemic Corticosteroids in Patients With Severe Eosinophilic Asthma
CompletedOBSERVATIONAL
Enrollment
27
Participants
Timeline
Start Date
January 25, 2016
Primary Completion Date
October 31, 2017
Study Completion Date
October 31, 2017
Conditions
Asthma; Eosinophilic
Interventions
DRUG
Mepolizumab
Trial Locations (1)
38700
University Hospital Grenoble, La Tronche
All Listed Sponsors
lead
University Hospital, Grenoble
OTHER
NCT03453021 - Effect of Mepolizumab on Decrease of Systemic Corticosteroids in Patients With Severe Eosinophilic Asthma | Biotech Hunter | Biotech Hunter